Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2024 - Issue 6

Every Molecular Prediction Needs an Evidence Passport Linking Confidence, Applicability, Provenance, and Experimental Consequence Download PDF


, , ,
  1. Department of Molecular Prediction and Evidence Passports, Graduate School of Pharmacy, Kyoto University, Kyoto, Japan.
  2. Department of Confidence and Applicability Assessment, Faculty of Pharmacy, University of Bologna, Bologna, Italy.
  3. Department of Provenance and Experimental Consequence Tracking, Faculty of Pharmaceutical Sciences, University of Milan, Milan, Italy.
  4. Kabardino-Balkarian State University named after H.M. Berbekov, Kabardino-Balkarian Republic, Russia.

  5. North Caucasus Federal University, Stavropol, Russia.
Abstract

Molecular predictions increasingly influence which compounds are screened, synthesized, optimized, or advanced, yet the evidential conditions surrounding those predictions are often separated from the outputs that enter experimental workflows. A probability, rank, or predicted property can therefore travel farther than its calibration evidence, applicability limits, data provenance, model version, and intended use. This article develops a proposed molecular prediction evidence passport as an original prediction-governance construct for keeping those elements attached to a bounded prediction event. The approach synthesizes methodological insights from molecular machine learning, uncertainty quantification, biomedical data stewardship, reporting guidance, and pharmaceutical decision practice. The passport is defined as a versioned, machine-readable and human-interpretable record that identifies the prediction object; preserves model, code, representation, and data lineage; distinguishes model confidence from calibrated uncertainty; records applicability conditions and unresolved uncertainty sources; states the experimental decision the prediction may inform; and links subsequent experimental consequences back to the originating record. The central contribution is not another performance metric, but an architecture for preventing benchmark performance, explanation, plausibility, or organizational approval from being misread as experimental confirmation, mechanism, therapeutic value, or deployment readiness. The construct may support more inspectable handoffs across screening, optimization, and candidate selection, while enabling later audit of what was known, assumed, changed, and acted upon. Its value remains conditional on schema design, semantic interoperability, data quality, human oversight, and prospective evaluation. The passport is therefore presented as a testable governance proposal rather than a validated standard, regulatory artifact, or autonomous decision system.

Cite this article
Vancouver
Yamamoto H, Greco F, Bianchi A, Nakamura R. Every Molecular Prediction Needs an Evidence Passport Linking Confidence, Applicability, Provenance, and Experimental Consequence. Pharmacophore. 2024;15(6):66-75. https://doi.org/10.51847/WvgrULwuFS
APA
Yamamoto, H., Greco, F., Bianchi, A., & Nakamura, R. (2024). Every Molecular Prediction Needs an Evidence Passport Linking Confidence, Applicability, Provenance, and Experimental Consequence. Pharmacophore, 15(6), 66-75. https://doi.org/10.51847/WvgrULwuFS

Related articles:
Most viewed articles:
QR code:

Short Link:
Views: 68

Downloads: 20
Quick Access

Associations

Pharmacophore
ISSN: 2229-5402

Copyright © 2026 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.